|
|
|
Insider
Information: |
Link Max |
Relationship: |
Director |
City: |
8044 Zurich Switzerland |
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
9 |
|
Direct
Shares |
1,228,236 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$12,519,098 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
1,228,236 |
|
|
Total
Value |
$12,519,098 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Juniper Pharmaceuticals Inc |
JNP |
Director |
2003-08-08 |
23,000 |
2003-08-08 |
0 |
Premium* |
|
Cti Biopharma Corporation |
CTIC |
Director |
2005-09-30 |
73,572 |
2003-09-25 |
0 |
Premium* |
|
Windtree Therapeutics Inc |
WINT |
Director |
2007-03-09 |
166,821 |
2003-09-25 |
0 |
Premium* |
|
PDL Biopharma Inc |
PDLI |
Director |
2005-11-02 |
159,916 |
2003-09-25 |
0 |
Premium* |
|
Celsion Corp |
CLSN |
Director |
2012-12-10 |
380,385 |
2003-12-22 |
0 |
Premium* |
|
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2014-02-28 |
59,469 |
2004-04-06 |
0 |
Premium* |
|
Human Genome Sciences Inc |
HGSI |
Director |
2008-04-11 |
27,699 |
2007-07-10 |
0 |
Premium* |
|
Ladrx |
LADX |
Director |
2012-02-23 |
260,305 |
2007-04-27 |
0 |
Premium* |
|
Sintx Technologies Ord Shs |
SINT |
Director |
2014-08-12 |
77,069 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
69 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
WINT |
Windtree Therapeutics Inc |
Director |
|
2007-03-09 |
4 |
B |
$2.09 |
$83,768 |
D/D |
40,000 |
166,821 |
2.39 |
- |
|
CLSN |
Celsion Corp |
Director |
|
2011-08-09 |
4 |
OE |
$2.40 |
$40,999 |
D/D |
17,083 |
261,025 |
0 |
- |
|
CLSN |
Celsion Corp |
Director |
|
2008-11-17 |
4 |
B |
$2.60 |
$19,599 |
D/D |
7,100 |
120,462 |
2.39 |
- |
|
CLSN |
Celsion Corp |
Director |
|
2008-11-19 |
4 |
B |
$2.70 |
$5,670 |
D/D |
2,100 |
122,562 |
2.39 |
- |
|
CLSN |
Celsion Corp |
Director |
|
2012-09-20 |
4 |
OE |
$2.72 |
$95,200 |
D/D |
35,000 |
296,025 |
0 |
- |
|
CLSN |
Celsion Corp |
Director |
|
2011-05-26 |
4 |
B |
$2.77 |
$95,681 |
D/D |
34,542 |
197,104 |
2.39 |
- |
|
CLSN |
Celsion Corp |
Director |
|
2012-09-20 |
4 |
OE |
$2.77 |
$230,263 |
D/D |
70,360 |
366,385 |
0 |
- |
|
CLSN |
Celsion Corp |
Director |
|
2009-12-22 |
4 |
B |
$3.00 |
$29,967 |
D/D |
10,000 |
162,562 |
2.39 |
- |
|
CLSN |
Celsion Corp |
Director |
|
2007-02-27 |
4 |
B |
$3.49 |
$34,937 |
D/D |
10,000 |
97,466 |
2.39 |
- |
|
CLSN |
Celsion Corp |
Director |
|
2007-02-26 |
4 |
B |
$3.50 |
$35,027 |
D/D |
10,000 |
87,466 |
2.39 |
- |
|
CLSN |
Celsion Corp |
Director |
|
2009-08-10 |
4 |
B |
$3.71 |
$55,689 |
D/D |
15,000 |
152,562 |
2.39 |
- |
|
CLSN |
Celsion Corp |
Director |
|
2009-05-13 |
4 |
B |
$3.90 |
$58,565 |
D/D |
15,000 |
137,562 |
2.39 |
- |
|
CLSN |
Celsion Corp |
Director |
|
2006-03-17 |
4 |
B |
$4.03 |
$40,300 |
D/D |
10,000 |
70,800 |
2.39 |
- |
|
CLSN |
Celsion Corp |
Director |
|
2011-07-25 |
4 |
B |
$4.27 |
$199,998 |
D/D |
46,838 |
243,942 |
2.39 |
- |
|
JNP |
Juniper Pharmaceuticals I... |
Director |
|
2003-08-08 |
4 |
OE |
$4.81 |
$62,465 |
D/D |
13,000 |
23,000 |
|
- |
|
CLSN |
Celsion Corp |
Director |
|
2007-05-18 |
4 |
B |
$4.84 |
$48,400 |
D/D |
10,000 |
113,362 |
2.39 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2005-03-10 |
4 |
B |
$5.20 |
$26,000 |
D/D |
5,000 |
73,572 |
2.39 |
- |
|
PDLI |
PDL Biopharma Inc |
Director |
|
2003-09-25 |
4 |
OE |
$5.56 |
$189,040 |
D/D |
34,000 |
80,000 |
|
- |
|
HGSI |
Human Genome Sciences Inc |
Director |
|
2008-04-11 |
4 |
A |
$6.50 |
$6,370 |
D/D |
980 |
27,699 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2004-12-30 |
4 |
OE |
$6.63 |
$99,450 |
D/D |
15,000 |
68,572 |
|
- |
|
CLSN |
Celsion Corp |
Director |
|
2012-12-10 |
4 |
B |
$7.60 |
$106,400 |
D/D |
14,000 |
380,385 |
2.39 |
- |
|
HGSI |
Human Genome Sciences Inc |
Director |
|
2007-07-10 |
4 |
A |
$8.99 |
$3,749 |
D/D |
417 |
25,417 |
0 |
- |
|
HGSI |
Human Genome Sciences Inc |
Director |
|
2007-10-10 |
4 |
A |
$10.02 |
$4,749 |
D/D |
474 |
25,891 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2004-04-06 |
4 |
B |
$10.74 |
$169,914 |
D/D |
9,501 |
37,667 |
2.39 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2007-06-11 |
4 |
OE |
$10.74 |
$792,383 |
D/D |
35,166 |
82,743 |
0 |
- |
|
69 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|